Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC
Clinical trial NCT04275713 · COMPLETED
Trial details
- NCT number
- NCT04275713
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2024-06-11
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.